Universidad de los Andes   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bogotá Colombia (1948)

Organization Overview

First Clinical Trial
2006
NCT00277693
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinica de los Andes IPS | Clínica de Los Andes IPS | Department of Public Health, School of Medicine, Universidad de los Andes, Bogotá, Colombia | Faculty of Medicine, University Los Andes | Francisco Espinoza | Francisco Espinoza, MD | Professor School of Medicine | Universidad de los Andes | Universidad de Los Andes, Bogota, Colombia | Universidad de los Andes, Chile | Universidad Los Andes | Universidad Los Andes, Chile | University Los Andes | University of Los Andes | University of Los Andes, Columbia | University of Los Andes, School of Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Chronic Periodontitis (Phase 2)

Dental Pulp Exposure (Phase 3)

Diabetic Nephropathies (Phase 4)

Glomerulonephritis (Phase 2)

Kidney Diseases (Phase 4)

Lupus Erythematosus, Systemic (Phase 2)

Lupus Nephritis (Phase 2)

Metabolic Syndrome (Phase 3)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Periodontitis (Phase 2)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 18